SELAS PHARMACIE DU CENTRE COMMERCIAL JAS DE BOUFFAN : revenue, balance sheet and financial ratios

In 2024, SELAS PHARMACIE DU CENTRE COMMERCIAL JAS DE BOUFFAN achieves revenue of 7.8 M€. Over the period 2017-2024, the company shows strong growth with a CAGR (compound annual growth rate) of +7.1%. After deducting consumption (5.5 M€), gross margin stands at 2.2 M€, i.e. a rate of 29%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 718 k€, representing 9.2% of revenue. This level of operating margin is satisfactory for the sector. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 498 k€, i.e. 6.4% of revenue. This profit can be retained or distributed to shareholders.

The debt ratio (= Financial debt / Equity x 100) stands at 31%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 63%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 2.3 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 6.7% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. Satisfactory level allowing partial financing of growth.

The liquidity ratio (= Current assets / Current liabilities) stands at 230.83. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 0.5x. Danger: operating income does not cover interest charges, unsustainable situation.

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 8 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 54 days. Excellent situation: suppliers finance 46 days of the operating cycle (retail model). Inventory turnover is 54 days (= Average inventory / Cost of goods x 360). Overall, WCR represents 68 days of revenue, i.e. 1.5 M€ to permanently finance. Over 2017-2024, WCR increased by +123%, requiring additional financing.

Based on 225 transactions of similar company sales in 2024, the value of SELAS PHARMACIE DU CENTRE COMMERCIAL JAS DE BOUFFAN is estimated at 6 196 850 € (range 4 390 267€ - 9 112 965€). With an EBITDA of 717 638€, the sector multiple of 9.2x is applied. The price/revenue ratio is 0.64x (in line with sector norms). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.